Home
Refresh   Tag(s): ; ; ;
Add to My Group
June 27, 2007 at 01:34:04

View Ratings | Rate It

MLB Bats Whittled Down to Uneven Playing Field

submit to twitter
submit to reddit
submit to digg

Tell A Friend

By Diane M. Grassi (about the author)     Page 2 of 2 page(s)

opednews.com     Permalink

 

The lack of restrictions on weight or the lack of prescribed storage care of bats by MLB, could have a profound impact on whether or not a bat breaks or explodes upon impact. Such endangers its players and spectators. Players go through an average of 60-70 bats a season. But the moisture content of the wood upon manufacture as well as in storage, whether the bat is hand-lathed or completely machine made, as well as the bat’s weight and handle diameter, could all alter the bat’s ultimate performance and longevity. Seattle Mariner, Ichiro Suzuki, for example, has his own humidor for his entire bat supply.

 

And why should a bat maker, such as Sam Holman, who produces several thousand bats each season to MLB as opposed to Hillerich and Bradsby's 750,000, foot a bill of $65,000.00 per year for liability insurance? The supposed interest in increasing liability insurance fees by MLB for bat makers is an easy way for MLB not to address the incessant breakage of its bats. Perhaps it is the quality of MLB bat inspectors, or a lack of a minimum quality standard of wood or the non-requirement of prescribed weight ratio of bat barrels to handles. But instead of MLB looking for a better standardization process for its bats, it would rather thrust the responsibility onto the bat makers, and thereby still leaving players and spectators at risk.

 

Also of note, according to Hillerich and Bradsby’s Chuck Schupp, head of its professional division, “We have a priority list of players. A lot of it is based on a personal relationship. If someone is loyal to us, we’ll take care of them.” And although players are not required to sign exclusivity contracts with bat makers, as individual teams assume all costs for players’ bats, Schupp says there is a “Louisville Slugger ‘A’ list.” It includes Alex Rodriguez, Derek Jeter, Jason Giambi, Carlos Delgado and Ken Griffey, Jr., among select others.

 

If star players are treated preferably by Schupp for their Louisville Slugger bats, does that mean that average or up and coming players are at a distinct disadvantage while not getting the best product from the same manufacturer? Should not MLB perhaps look into that?

 

And finally, unless MLB and its Commissioner is willing to look at all matters of inequity in its sport, whether it be an issue between players, between equipment manufacturers and its players, between baseball operations and its suppliers or a lack of standardization when it comes to equipment, MLB should not be permitted to point the finger exclusively at the use of performance enhancing drugs as the sole threat to the sanctity of the game. For that is far from the only difference-maker in varying performance results in the game of MLB today.

 

And if MLB wants to be taken seriously in preserving the integrity of the game, it must do a far better job of it rather than its present lethargic effort. For certainly, they are not fooling the fans and the fans and the players deserve better.

  

Copyright © 2007 Diane M. Grassi

Contact: dgrassi@cox.net

Next Page  1  |  2

 

dianemgrassi.blogspot.com

Diane M. Grassi is an investigative journalist and reporter providing topical and in-depth articles and analysis on U.S. public policy and governmental affairs, including key federal and state legislation as well as court decisions relative to the (more...)
 

The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.

Contact Author Contact Editor View Authors' Articles

 

Book Recommendations for "Business Industry Drug Policy"
The Japanese Pharmaceutical Industry: The New Drug Lag and the Failure of Industrial Policy (Elgar Monographs)
by L. G. Thomas

$115.00

Number of pages: 215
Publisher: Edward Elgar Publishing

A blue ribbon drug policy.: An article from: Behavioral Health Management
by Michael J. Stoil

$5.95

Number of pages: 6
Publisher: Medquest Communications, LLC

Competitive Strategies in the Pharmaceutical Industry
by Robert B. Helms


Number of pages:
Publisher: Aei Pr

View All Book Recommendations

Share this page: (what's this?)                   Tell a Friend: Tell A Friend

FACEBOOK      DIGG THIS      Add This Page to Mr Wong!           NEWSVINE      DEl.ICIO.US      Looksmart Furl      NETSCAPE      My Web      Tag!RawSugar      Blink List     (More...)

Comments: Expand   Shrink   Hide  
3 comments
To view all comments:
Expand Comments
 

Diane by Professor Emeritus Peter Bagnolo on Wednesday, Jun 27, 2007 at 8:38:20 AM
Is baseball different than wrestling? by Robert Chapman on Wednesday, Jun 27, 2007 at 10:19:31 AM
Is Baseball different than Wrestling? by Alessandro Machi on Thursday, Jun 28, 2007 at 1:24:11 AM

 
Want to post your own comment on this Article? Post Comment


 

 

 

Tell a Friend: Tell A Friend

Copyright © 2002-2009, OpEdNews

Powered by Populum